To combat bacterial resistance against antibiotics, glycosyltransferase inhibiting molecules, which block the synthesis of the pre-cursor of the bacterial cell wall, need to be discovered and developed. In this study, we demonstrate that phenylphenoxybenzamide, a salicylanilide, is not a glycosyltransferase inhibiting molecule, despite claims in literature to the contrary, and through our work show that glycosyltransferase construct choice and detergent choice are crucial parameters to consider when designing glycosyltransferase assays that aim to discover and develop molecules that inhibit these types of enzymes.
Introduction
The emergence of bacterial resistance to common antibiotics [1] has prompted initiatives to search for new antibiotics against existing antibiotic targets, for example, enzymes that synthesize peptidoglycan. Peptidoglycan provides mechanical strength to Gram-positive and Gram-negative bacteria, which allows these bacteria to withstand osmosis-induced turgor pressure caused by ionic strength fluctuations in the bacterium's environment [2] . Peptidoglycan is synthesized from GlcNAc-MurNAc-pentapeptide-diphosphate-undecaprenyl (lipid II) [3, 4] by class A penicillin binding proteins (PBPs) [5] . The N-terminal domain of a PBP encodes a glycosyltransferase (GT).
This GT catalyzes a cation cofactor-dependent reaction that results in the formation of a β-1,4 covalent bond between the C4 O-atom of the GlcNAc sugar of lipid II (bound in the acceptor pocket of the active site of the GT) and the C1-atom of the MurNAc sugar of lipid II (bound in the donor pocket). The product subsequently translates through the active site of the GT, after which another lipid II molecule binds the now vacant acceptor pocket. Consecutive reactions result in a lipid II polymer [6, 7] , which during the GT-catalyzed reaction, is integrated into pre-existing peptidoglycan by the C-terminal domain of the PBP that catalyzes a transpeptidase (TP) reaction [5] . While PBPs build up and strengthen the peptidoglycan layer that surrounds a bacterium, lytic transglycosylases weaken the peptidoglycan layer by cleaving the β-1,4 covalent bond created by PBPs [9] . Compounds that bind and inhibit the reactions catalyzed by PBPs will thus negatively affect the strength of the bacterial cell wall and are therefore sought after since they can be potentially used as antibiotics. β-lactam antibiotics inhibit the TP reaction catalyzed by PBPs, however bacteria have developed resistance to these types of antibiotics, rendering them less effective in treating bacterial infections [9, 10] . Therefore attention has shifted towards molecules that inhibit the GT-catalyzed reaction by PBPs. Examples are moenomycins and moenomycin analogues [11] , monosaccharides ACL20215 and ACL20964 [12] , and lipid II substrate analogues [13, 14] . More recently, non-saccharide molecules, such as salicylanilides [15] , Albofungin (a xanthone) and TAN1532B (a benzo[a]tetracene) were discovered to inhibit the GT-catalyzed reaction [16] . In this research we employ a monoglycosyltransferase from S. aureus (SaMGT), a class A PBP without a TP domain (CAZy: GT51), to reveal that phenylphenoxybenzamide (ppb, fig.   1 (3), a salicylanilide) is not a GT inhibitor, and in the process establish GT assay design principles that will facilitate GT inhibitor identification and development.
Materials and Methods
Transformation and Expression of ng of DNA (pET15b   encoding truncated SaMGT with an N-(Δ28-269, table 1 (2)) or C-terminal linker (Δ68-269, table 1 (3)) containing a His 6 -tag (confirmed by sequencing)) was added to a vial containing 100 μl thawed E. coli Bl21(DE3) competent cells (RBC Biosciences) kept at 4 ºC. The suspension was mixed, transferred to a water bath for transformation (42 ºC, 1 min), returned to ice, and finally pipetted onto a TB agar plate containing 100 μg/ml carbenicillin. The plate was incubated overnight at 37 ºC and bacterial colonies used to inoculate a 100 ml TB pre-culture (100 μg/ml carbenicillin, same temperature, 180 rpm). After 17 h, 5 ml pre-culture was used to inoculate 1 L pre-heated TB medium (50 μg/ml carbenicillin, added prior to inoculation, 37 ºC, 180 rpm) and at OD 0.5-0.6 (reached within 3 h) 0.36 g of IPTG powder was added to induce expression of Δ28-269 (2MGT, Table 1 ) or Δ68-269 SaMGT (6MGT). After 3 h the medium was collected and centrifuged to harvest the E. coli cells, after which the cell pellet was collected, frozen (-20 ºC) and stored until further use.
Purification of 2MGT -To each gram of frozen cell pellet 10 μl 1 mg/ml DNase I (Sigma) and 20 μl 50 mg/ml lysozyme were added, then 30 ml buffer A (20 mM Tris-HCl pH 8, 200 mM NaCl) and one cOmplete EDTA-free protease inhibitor tablet (Sigma). After thawing, and homogenization by vortexing, the cell solution was passed thrice through a microfluidizer device.
The volume of the flow-through was then adjusted to 50 ml with buffer A, n-Decyl-β-D-Maltopyranoside (DM, Anatrace) powder was added (483 mg, 20 mM), incubated (2 h, RT, Intelli Mixer, 4 rpm) and centrifuged (Eppendorf 5810R, 10 .000 rpm, 10 min) to remove non-solubilized material. The supernatant was decanted, centrifuged once more and loaded onto a 1 ml HisTrap HP column with an ÄKTA FPLC pre-equilibrated with buffer B (20 mM Tris-HCl pH 8, 200 mM NaCl, 50 mM imidazole pH 8 and 2 mM DM). The column was washed with buffer B (15 column volumes), disconnected from the FPLC system, and loaded with 1.1 ml buffer B mixed with 20 μl thrombin (1 unit thrombin per μl 1X PBS) and incubated overnight (23 ºC) to release bound 2MGT. After 20 h the column was reconnected to the FPLC system, washed with buffer B, the flow-through collected, concentrated (Amicon, 10.000 MWCO) and further purified with a Superdex 200 10/300 GL column (GE Healthcare) equilibrated in 200 mM NaCl, 2 mM DM and 20 mM Tris-HCl pH 8 (buffers C) or Na HEPES pH 8 (buffer C'). The purified protein (Figs. S1 &S2) was collected, and either used for crystallization experiments after concentration (buffer C), or frozen (-20 ºC) and after thawing used for enzyme assays (buffer C'). Preparation of bicelle solution -To make bicelle solution [18] 5 mg CHAPS detergent (GE), 15 mg DMPC (Avanti Polar Lipids) and 100 μl ultra-pure water (Milli-Q) were mixed, heated to 42 ºC (10 min), vortexed, put on ice (10 min), vortexed again, and these steps repeated until all solid material was dissolved. The solution was kept on ice for use in crystallization experiments, or was frozen (-20 ºC).
Diffraction data processing -The diffraction data collected from a 2MGT crystal were indexed with Mosflm (space group P1) [19] , scaled and merged with Scala, after which a selfrotation function was calculated with Molrep. This revealed the presence of three perpendicular 2fold axes. The data were indexed, scaled and merged again (P222) and the presence of two screw axes established along a and c (confirmed with Pointless). To generate P2 1 2 1 2 from P222 Reindex was applied with operator h=l, k=h, l=k. The data were then truncated (ellipsoidally) and scaled (anisotropically) using the diffraction anisotropy server (https://services.mbi.ucla.edu/anisoscale/)
[20] and reflections assigned to R free (5.6 %) with Uniquefy. Refinement statistics for the model are reported in Table S1 .
Construction, transformation, expression and purification of transmembrane domain-less
6MGT -The transmembrane (TM) domain of 2MGT was identified with Phobius [27] (see Results) and two primers 5' CATGCCATGGATAATGTGGATGAACTAAG -3' (forward) and 5' CGCGGATCCTCATCAGTGATGATGATGATGATGGCTGCTGCCGCTGCCGCGCGGCACCA GACGATTTAATTGTGACATAGCC -3' (reverse) designed to construct 6MGT from the 2MGT encoding pET15b plasmid. After PCR the DNA product was purified, restricted with NcoI and BamHI, ligated into a pET15b vector and sequenced. After transformation of E. coli Bl21(DE3) cells with the 6MGT encoding plasmid, 6MGT was expressed and purified as described (2MGT) although the last purification step utilized a Superdex75 10/300 GL column equilibrated in buffer C' without DM (Figs. S1&S2).
Enzyme assay design-To test whether purified MGT (2MGT or 6MGT) was able to polymerize NDB-lipid II ( Fig. 1 (1) ), NBD-lipid II (lipid II) was pipetted into an eppendorf tube from a stock solution dissolved in MeOH. The tube was transferred into a fume-hood, and the MeOH allowed to evaporate. A buffer, a catalyst, a detergent and/or organic solvents were added followed by purified enzyme. This resulted in an enzyme assay volume of 20 μl, an enzyme concentration of 0.2 μM and a lipid II concentration of 4 μM. The eppendorf tube was then, without delay, transferred into an eppendorf thermomixer R (1400 rpm), and the enzymatic reaction (after time) stopped by the addition of 1 μM moenomyin A (moeA, fig. 1 (2), [28] ). Next, 200 μg lysozyme was added to convert lipid II polymer into NBD-GlcNAc-MurNAc-dissacharide (room temperature, 2 h) and the mixture analyzed as described by Wu et al. [16] . To test the inhibition of MGT by moeA, moeA was added to the enzyme assay solution prior to adding purified enzyme. To test whether MGT was inhibited by ppb ( Fig. 1 (3) ) or TAN1532B ( Fig. S4 (4) , 2MGT only) either compound (dissolved in MeOH) was added to an eppendorf tube together with lipid II, then placed in a fume-hood, and after evaporation of MeOH, used to assay enzymatic activity (Figs. 4, 5 and 6) .
Growth of S. aureus cells and extraction of S. aureus lipids -S. aureus strain ATCC 29213
was used to inoculate 5 ml neutral broth (37 ºC). The cells were grown for 19 h, after which the preculture was used to inoculate 2 L neutral broth, and continued for 19 h (37 ºC). The cells were then harvested and frozen (-80 ºC). To 0.9 g S. aureus cell pellet (from 200 ml culture) ultra-pure water was added, as well as NaCl (500 mM), lysozyme (100 mg) and DNase I (0.1 mg). The suspension (2.5 ml) was incubated for 2 h at 37 ºC, vortexed every half hour, and transferred into a 100 ml glass vial. While vortexing, 50 ml hexane isopropanol (3:2 [29]) was added to the cell suspension.
The mixture was left to settle for 30 min and the solvent harvested. Samples were taken for thin layer chromatography analysis (Fig. S3 ). The stationary phase was silica gel 60G F254 (Merck), the mobile phase was a mixture of chloroform (65 %), methanol (25 %) and acetic acid (10 %), and staining of the phospholipids was performed with CuSO 4 (100 mg/ml) [30] . The solvent was subsequently roto-evaporated to dry-ness, which yielded 30 mg S. aureus lipid powder. A 2 % wt/vol S. aureus lipid solution was subsequently made by adding an appropriate volume of ultrapure water followed by rigorous vortexing.
Dynamic light scattering -To investigate the dispersity of size exclusion purified 6MGT, the enzyme was diluted with buffer (20 mM Na HEPES pH 7.5, 1 mM MnCl 2 , 200 mM NaCl) to 0.1 mg/ml, pipetted into a quartz cuvette (QS 3 mm, Hellma) and measured (30 ºC) with a Zetasizer Nano ZS dynamic light scattering system (Fig. 3) .
Modelling -To predict a potential interaction between ppb and the quarternary structure of TM-less 68MGT (Fig. 2D , PDB code 3HZS, a trimer), ppb was drawn in ChemDraw and topologies generated with PRODRG [31] then together with the protein target (without bound moeA, PO 4 , and H 2 O) submitted to SwissDock [32] (Fig. 7) .
Results
SaMGT and SaMGT truncates -In this study we used a monoglycosyltransferase (MGT) from S. aureus (SaMGT) to investigate how a non-saccharide salicylanilide (Fig. 1 (3) , ppb) inhibited the SaMGT-catalyzed lipid II polymerization reaction, as a general model for how the PBP GT-catalyzed reaction was inhibited by salicylanilides. SaMGT is a 31 kDa enzyme (Table 1 (1)) that is composed of three domains: a cytoplasmic domain (residues 1-41), a transmembrane (TM) domain (residues 42-64, ILLKILLTILIIIALFIGIMYFL, fig. 2A ), and a membrane-associated periplasmic domain (residues 65-269) that catalyzes a lipid II polymerization reaction. SaMGT degrades during purification (data not shown), unlike Δ28-269 SaMGT (2MGT, table 1 (2)). A 3D structure of 2MGT has been elucidated (PDB code 3VMQ [23] , and this research (Table S1, 1 (3) ), a TM-less SaMGT construct analogous to TM-less 68MGT, oligomerizes in solution (Fig. 3) , just as TM-less Δ68-268 (table 1 (5)) [35] and TM-less Δ68-269 SaMGT (table 1 (6)) [36] .
Structural investigation into 2MGT ppb inhibition -In an attempt to gain insight into the inhibition of the SaMGT-catalyzed reaction by ppb ( Fig. 1 (3) ), 2MGT was purified as described (for reasons of simplicity) and initially crystallized in the absence of ppb. Several well diffracting protein crystals were obtained that crystallized in an orthorhombic space group. 2MGT crystallizes as a monomer (Table S1 ) and its 3D structure is similar to the 3D structure of 2MGT deposited under PDB code 3VMQ (2 molecules per ASU) [23] with an RMSD over 180 Cα-atoms of 0.4 Å (chain A of 3VMQ) and 0.7 Å (chain B). The 3D structure is further similar to the 3D structure of moeA bound TM-less 68MGT with an RMSD of 0.8 Å over 161 Cα-atoms (monomer A). The 2MGT 3D structure has three three flexible elements, which are, as a consequence, only partly defined by electron density. One of these elements is the N-terminal α-helix ( Fig. 2A) . The other This revealed that 2MGT was active and polymerized NBD-lipid II (lipid II) and that the presence of moeA or ppb in the assay condition led to the inhibition of the 2MGT-catalyzed reaction (data not shown). The enzyme assay conditions were then altered to more closely resemble the assay conditions used by Terrak et al. [35] . 2MGT was found to be active and to be inhibited by moeA and ppb ( Fig. 4 (A1-A5) ). C 10 E 8 (octaethylene glycol monodecyl ether, decyl-PEG) was subsequently substituted for n-decyl-β-D-maltopyranoside (DM). 2MGT polymerized lipid II, moeA inhibited 2MGT, but ppb did not inhibit the 2MGT-catalyzed lipid II polymerization reaction ( Fig. 4 (B1-B5) ).
Isolation of lipids from S. aureus cells and inhibition of 2MGT by ppb -To further
investigate this result, C 10 E 8 and DM were substituted for lipids directly isolated from S. aureus cells (Fig. S3 ). The S. aureus extract contained two types of lipids with R f values similar to lipids present in the E. coli total lipid extract, and one lipid (nearest to the spot origin, presumably lysylphosphatidylglycerol (LPE) [30] ) not present in the E. coli lipid extract and thus specific to S. aureus. 2MGT polymerized the lipid II substrate (Fig. 4 (C1) ) and the presence of moeA in the assay condition led to the inhibition of 2MGT (Fig. 4 (C5), Fig. 5C ). 2MGT was not inhibited when the enzyme assay condition contained ppb (Fig. 4, C2-C4 ), but 2MGT was inhibited in the presence of TAN1532B (Fig. S4 (4), fig. 5B ).
Inhibition of TM-less 6MGT by ppb and modelling of the 68MGT ppb interaction -A final
experiment was subsequently devised and ppb inhibition of TM-less 6MGT tested in an enzyme assay condition (without detergent) in which 6MGT oligomerized (Fig. 3) . 6MGT was active and polymerized lipid II (Fig. 6A) , was inhibited when the assay condition contained moeA (Fig. 6C) , and, surprisingly when the assay condition contained ppb (Fig. 6B) . The interaction between ppb and oligomeric 6MGT was modeled with the 3D structure of trimeric 68MGT, which revealed ppb bound, in various orientations (models), in a hydrophobic pocket formed by chain A, B and C of the 68MGT trimer ( Fig. 7A, C) .
Discussion

Structural investigations into glycosyltransferase inhibition by ppb, a non-saccharide
salicylanilide inhibitor -In this study we attempted to elucidate a 3D structure of Δ28-269 SaMGT (2MGT) with bound phenylphenoxybenzamide (Fig. 1 (3) , ppb) with the aim to facilitate structurebased salicylanilide (antibiotic) design. Despite multiple attempts, a 3D structure of 2MGT with bound ppb was eventually not elucidated. To explain this lack of success, it was hypothesized that 2MGT had not bound ppb during ppb treatment and co-crystallization or had bound ppb, but had bound ppb through its flexible TM-domain (hydrophobic) and therefore could not be resolved.
Alternatively, it was hypothesized that 2MGT had bound ppb, but could not maintain bound ppb upon crystallization, as exemplified by the inability of crystallized 2MGT to bind moenomycin A (moeA) (Fig. 2C) or as a consequence of crystallization induced non-specific contacts [38] , as exemplified by element A (in)flexibility in the 3D structures of 2MGT and Δ28-268 SaMGT (68MGT) (Fig. 2B) . Last, it was hypothesized that ppb was not an inhibitor of 2MGT, but appeared to be, as a consequence of the protocol used [16] to assay glycosyltransferase (GT) ppb inhibition.
Ppb is not a GT inhibitor -To test this hypothesis, we employed a) 2MGT to exclude the possibility that enzyme assay results were influenced by domains found in structurally more complex PBPs (see Introduction) and b) varied enzyme assay conditions to probe whether ppb inhibition of 2MGT enzymatic activity was assay condition-dependent. The protocol outlined by Wu et al. [16] was initially used, and the result showed that ppb inhibited 2MGT (data not shown), which suggested that ppb was indeed a GT inhibitor [15] . The enzyme assay condition was then altered to resemble the enzyme assay condition used by Terrak et al. [36] to investigate the kinetic properties of TM-less Δ68-268 SaMGT (Table 1 (6) ). However, organic solvents were omitted to avoid assay component concentration changes as a consequence of MeOH evaporation, and to avoid the possibility that the solvents affected the 2MGT native structure [39] . The results showed that 2MGT was active, was inhibited by moeA and was inhibited by ppb ( Fig. 4 (A1-A5) ). This experiment revealed that the inhibition of 2MGT by ppb, despite substantial assay condition changes, could be reproduced. However, upon termination of the 2MGT-catalyzed reaction, and analysis of the reaction mixture contents, a substantial amount of lipid II substrate remained unconverted ( Fig. 4 (A1) ). This was attributed to the temperature used to perform the assay (30 ºC) and to lipid II substrate aggregation in the absence of organic solvents [40] . Next, C 10 E 8 was substituted for the disaccharide-based detergent n-decyl-β-D-maltopyranoside (DM) and the experiment repeated. 2MGT was active, 2MGT was inhibited by moeA, but 2MGT was not inhibited by ppb ( Fig. 4 (B1-B5) ). These results suggested that ppb was not a GT inhibitor, contrary to earlier observations, and that ppb inhibition of 2MGT was detergent-dependent. For this reason, C 10 E 8 , DM and artificial detergents in general, were dispensed with, and substituted for lipids directly extracted from S. aureus cells (Fig. S3 ) via a method previously described by Hara et al.
[40] and validated by Kolarovic et al. [41] with the aim to mimic the native lipid environment of SaMGT, the bacterial plasma membrane. This allowed the enzyme assay time to be reduced from ≥ 2 hr (C 10 E 8 and DM) to ≤ 10 min ( Fig. 4 (C1) ). A similar observation was made by Newman et al.
[42], who showed that lactose permease enzymatic activity increased significantly when reconstituted into liposomes prepared from crude E. coli phospholipid extract instead of octyl-β-Dglucopyranoside. Under these enzyme assay conditions, 2MGT was inhibited by moeA ( Fig. 4 (C5) , Fig. 5C ), but ppb failed to inhibit the 2MGT-catalyzed reaction (Fig. 4 (C2-C4) ). Thus while moeA inhibited 2MGT effectively under all assay conditions in comparison to ppb, ppb inhibition of 2MGT was C 10 E 8 -dependent, which showed that ppb was not a genuine GT inhibitor, a conclusion further strengthened by the inhibition of 2MGT by TAN1532B (Fig. 5B) [16] .
Ppb binds 6MGT and modelling of the 68MGT ppb interaction -To further validate this conclusion, 2MGT was substituted for TM-less 6MGT, which oligomerized under assay conditions without detergent (Fig. 3) in accordance with TM-less Δ68-269 [35] and .
6MGT was active and polymerized lipid II, moeA inhibited 6MGT and, contrary to expectations, 6MGT was inhibited by ppb ( Fig. 6B ). However, inspection of the 3D structure of 2MGT revealed that it's periplasmic domain (6MGT) lacked a pocket lined with hydrophobic residues that could accommodate ppb. It was therefore hypothesized that ppb bound/sequestered lipid II. This was proven incorrect after Wu et al. [16] showed that TM-less and TP-less truncates of A. baumannii PBP1b and C. difficile PBP bound ppb in the absence of lipid II. The fact that 2MGT crystallized as a monomer, whereas TM-less Δ68-268 SaMGT (68MGT) crystallized as a trimer (Fig. 2D ) and TM-less 6MGT, under assay conditions, assembled into oligomers, among which trimers (Figs. 2D & 3) led to the hypothesis that ppb bound oligomeric rather than monomeric 6MGT. To investigate this hypothesis, a docking experiment was performed with 68MGT (trimer) and ppb, as a model for how a trimer of 6MGT may bind ppb. This experiment revealed that ppb bound a hydrophobic pocket lined by the F150's of chain A, B and C of 68MGT (I186 and L227 in CdPBP and AbPBP1b, respectively) and showed that bound ppb simultaneously occupied the moenocinol side chain binding pockets of moeA (Fig. 7B, D) , which explained why ppb, under assay conditions, inhibited the 6MGT-catalyzed lipid II polymerization reaction. However, oligomerization of Δ68-269 and Δ68-268 SaMGT was shown to be detergent-sensitive [35, 36] , and comparison of the 3D structure of 68MGT with that of 2MGT ( Fig. 2D ) showed that steric hindrance would prevent 2MGT monomers from assembling into the same configuration as 68MGT monomers upon trimerization.
This suggested that 2MGT would not be able to bind ppb even in an oligomerization event, in contrast to 68MGT. For these reasons, ppb inhibition of 6MGT, under assay conditions, was concluded to represent an artifact. Our investigations thus reveal that construct choice, and detergent choice strongly affect GT assay results and show that it is imperative that GT assays are thoroughly validated before being applied to screen for GT inhibitors, in order to avoid falsepositives [43] . and GIMP. 
